Literature DB >> 12709063

Initiation of JC virus DNA replication in vitro by human and mouse DNA polymerase alpha-primase.

Richard W P Smith1, Heinz-Peter Nasheuer.   

Abstract

Host species specificity of the polyomaviruses simian virus 40 (SV40) and mouse polyomavirus (PyV) has been shown to be determined by the host DNA polymerase alpha-primase complex involved in the initiation of both viral and host DNA replication. Here we demonstrate that DNA replication of the related human pathogenic polyomavirus JC virus (JCV) can be supported in vitro by DNA polymerase alpha-primase of either human or murine origin indicating that the mechanism of its strict species specificity differs from that of SV40 and PyV. Our results indicate that this may be due to differences in the interaction of JCV and SV40 large T antigens with the DNA replication initiation complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709063     DOI: 10.1046/j.1432-1033.2003.03579.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Host-specific replication of BK virus DNA in mouse cell extracts is independently controlled by DNA polymerase alpha-primase and inhibitory activities.

Authors:  Irina Tikhanovich; Heinz Peter Nasheuer
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Restriction of human polyomavirus BK virus DNA replication in murine cells and extracts.

Authors:  Cathal Mahon; Bo Liang; Irina Tikhanovich; Johanna R Abend; Michael J Imperiale; Heinz P Nasheuer; William R Folk
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 3.  Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV.

Authors:  Sue VandeWoude; Jennifer Troyer; Mary Poss
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

4.  Detection of JC virus-specific immune responses in a novel humanized mouse model.

Authors:  Chen Sabrina Tan; Thomas A Broge; Edward Seung; Vlad Vrbanac; Raphael Viscidi; Jennifer Gordon; Andrew M Tager; Igor J Koralnik
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.